prof. Valérie Fonteyne (MD, PhD)
Associate professor (Faculty of Medicine and Health Sciences, UGent)
Radiation oncologist (UZ Gent)
Research focus
Research is focused on urothelial cancers with strong research focus on optimalisation of treatment of prostate cancer, and more specifically node positive prostate cancer, and bladder cancer. The latter research focuses on optimization of diagnostics, intensification of treatment and optimization of bladder sparing therapies, development of care pathways and development of decision tools.
Another interest of research is treatment of oligometastatic disease in uro-oncological settings.
She is principal investigator of several phase 2-3 trials in prostate cancer and bladder cancer.
Interest lies in advancing precision oncology by minimizing the side effects of radiotherapy, thereby directly improving patients' quality of life. Research is conducted within the FWO-supported PRONANOTOX project, which pioneers advanced methodologies to predict and reduce radiation-induced toxicity in localized prostate cancer.
Biography
- 1996-2003: Medical faculty: Ghent University, Ghent, Belgium
- 2003-2010: Residency: Ghent University Hospital
- 2010: PhD: Intensity modulated radiotherapy and arc therapy for prostate cancer: clinical results and new perspectives
- 2010-current: Radiation oncologist: Ghent University Hospital
- 2017-2022: Post doctorate clinical specialist (Belgian Foundation against Cancer)
- 2012-current: Associate Professor at Ghent University
- Panel member EAU (European Association of Urology)
Research team
- Prof. Sofie Verbeke
- Prof. Pieter Devisschere
- Prof. Geert Villeirs
- Prof. N. Lumen
- Prof. C. Van Praet
- Dr. C. Berquin
- Dr. D. Demaeseneer
- Dr. F. Verghote
- Emma Van Damme - study coordinator